Form 8-K - Current report:
SEC Accession No. 0001104659-24-048076
Filing Date
2024-04-17
Accepted
2024-04-17 07:15:14
Documents
15
Period of Report
2024-04-12
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm2411935d1_8k.htm   iXBRL 8-K 31728
2 EXHIBIT 99.1 tm2411935d1_ex99-1.htm EX-99.1 7763
3 GRAPHIC image_001.jpg GRAPHIC 3603
  Complete submission text file 0001104659-24-048076.txt   216564

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20240412.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20240412_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20240412_pre.xml EX-101.PRE 22372
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2411935d1_8k_htm.xml XML 3361
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 24849364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)